tirzepatide ndc Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Medisca Inc | Tirzepatide |

Presented at: The 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease

GLP-1 drugs and erectile dysfunction have become one of the most common worries men bring to my clinic, usually a few weeks after starting Ozempic, Wegovy, Mounjaro, or Zepbound

These products are not for human consumption or therapeutic use

This makes it particularly harmful because it: delivers fatty acids directly to the liver worsens liver insulin resistance drives inflammation drives up sdLDL that cannot easily be removed by LDL receptors (and is principle cause of coronary artery disease) accelerates cardiovascular disease Visceral fat becomes both a marker of metabolic overload and a driver of further damage